Liyun Xue

644 citations
34 papers · 459 indexed · h-index 12
Topics
Renal cell carcinoma treatment (12 papers)Liver Disease Diagnosis and Treatment (12 papers)Renal and related cancers (9 papers)
Partner nations
ChinaJapanSingapore

In The Last Decade

Liyun Xue

26 papers receiving 456 citations

Peers

Liyun Xue
Comparison fields: 5 of 57
  • Pulmonary and Respiratory Medicine 227
  • Radiology, Nuclear Medicine and Imaging 201
  • Molecular Biology 147
  • Biomedical Engineering 107
  • Hepatology 82
Replace Karolin J. Paprottka with:
Karolin J. Paprottka Germany
Cindy F. Connell United States
Chengli Li China
Shengsheng Lai China
Donghong Shi China
Giuseppe Macis Italy
Michael F. Hoey United States
Myrosia T. Mitchell United States
A.D. Strickland United Kingdom
Aaron Maxwell United States
Liyun Xue relative to Karolin J. Paprottka Germany Karolin J. Paprottka's profile →
Citations per field
00.5×5.9×
Karolin J. Paprottka · 1×
Citations per year

Countries citing papers authored by Liyun Xue

Since Specialization
Citations

This map shows the geographic impact of Liyun Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyun Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyun Xue more than expected).

Fields of papers citing papers by Liyun Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liyun Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyun Xue. The network helps show where Liyun Xue may publish in the future.

Co-authorship network of co-authors of Liyun Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Liyun Xue. A scholar is included among the top collaborators of Liyun Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liyun Xue. Liyun Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 0
5 0
6 6
7 3
8 0
9 48
10 89
11 23
12 30
13 30
14 24
15 51
16 12
17 23
18 1
19 10
20 1

About Liyun Xue

Liyun Xue is a scholar working on Hepatology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 34 papers that have together received 459 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (12 papers), Liver Disease Diagnosis and Treatment (12 papers) and Renal and related cancers (9 papers). The work is most often cited by research in Hepatology (82 citations), Radiology, Nuclear Medicine and Imaging (201 citations) and Pulmonary and Respiratory Medicine (227 citations). Liyun Xue has collaborated with scholars based in China, Japan and Singapore. Frequent co-authors include Beijian Huang, Wen‐Ping Wang, Qing Lü, Hong Ding, Qing Lü, Lixia Yan, Cuixian Li, Yuli Zhu, Wenping Wang and Wenping Wang. Their work appears in journals such as Advanced Materials, Advanced Functional Materials and Advanced Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026